Table 3.
Adverse effects after stereotactic ablative radiotherapy, n (%)
| Adverse effect | Grade 1 | Grade 2 | Grade 3 |
|---|---|---|---|
| Acute adverse event | |||
| Dermatitis | 16 (24.6) | 3 (4.6) | 2 (3.1) |
| Radiation pneumonitis | 49 (75.4) | 7 (10.8) | 1 (1.5) |
| Dyspnea/shortness of breatha | 11 (16.9) | 8 (12.3) | 0 |
| Fatigue | 7 (10.8) | 2 (3.1) | 0 |
| Hemoptysis | 1 (1.5) | 0 | 0 |
| Late adverse event | |||
| Chest wall pain | 15 (23.1) | 7 (10.8) | 1 (1.5) |
| Rib fracture | 13 (20.0) | 3 (4.6) | 0 |
| Brachial plexopathy | 3 (4.6) | 2 (3.1) | 0 |
Toxicity was graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0. Each symptom was scored separately. Late event was defined as >6 months after SABR.
a
Grade 2 event was also regarded as symptom that is related to radiation pneumonitis.